Mini-Symposium Cancer Radiotheranostics

13:00-13:40: Revolutionizing Cancer Therapy: The Impact of Radiotheranostics in Nuclear Medicine
Tim Van den Wyngaert, MD, PhD – Nuclear Medicine Physician
Department of Nuclear Medicine, Antwerp University Hospital

13:40-14:20: Design and challenges of radiopharmaceuticals: The theranostic approach
Frederik Cleeren, PhD – Radiopharmacist
Faculty of Pharmaceutical Sciences, KU Leuven

14:20-15:00: New chemical tools for the production of ²¹¹At-labeled radiopharmaceuticals
François Guérard, PhD – Radiochemist
Cancer and Immunology Research Center, University of Nantes

16:00-18:00: Design, synthesis, and evaluation of trans-cyclooctene (TCO) and cis-dioxolane fused TCO (d-TCO) probes for bioorthogonal pretargeted PET imaging
PhD defence, Karuna Adhikari